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SUMMARY.-Injections of syngeneic bone marrow cells to adult C57BL/6 mice
treated DMBA intragastrically failed to prevent lymphoma induced by the
chemical.
The present results seem to indicate that bone marrow cells do not hasten
the regeneration of the transient injured thymus by DMBA as compared with
their effect in irradiated mice.
It appears that, under the conditions used, DMBA does not cause significant
damage to the bone marrow since marrow cells from chemically treated mice
were as effectiveasnormalmarrowcellsin:(a)preventingradiogenicleukaemia,
(b) repairing radiation damage ofthe thymus, (c) preventing the lethal action of
high doses of irradiation.
Marrow cells failed to restore antibody formation to Shigella depressed by
DMBA as they do in irradiated mice.
The results strengthen our previous view on the critical role ofbone marrow
on the effects caused by irradiation and not in the leukaemia process as such.
IT has been reported previously (Chen and Berenblum, 1968) that syngeneic
bone marrow cells injected into methylcholanthrene (MC) treated DBA/2 mice
failed to inhibit lymphoma induction, in contrast to its inhibiting effect on
radiation induced leukaemia.
The high incidence of lymphoma in DBA/2 mice achieved by chemical treat-
mentwasin contrastwiththelow occurrence ofthis tumourinducedbyirradiation.
In mice with a high susceptibility to radiogenic lymphoma, the induction of
lymphoma by chemicals was limited either to new-born mice or to adults by
administering the chemical for a long period of time. These obstacles prevented
an adequate comparison ofthe inhibitory effect ofbone marrow cells in lymphoma
induced by chemical or physical agents. The successful production oflymphoma
in adult C57BL/6 mice (Haran-Ghera, 1967) by gastric instillation of 7,12-di-
methylbenz(a)anthracene (DMBA) provides a suitable method ofovercoming these
difficulties.
This paper reports additional experiments concerning the influence of DMBA
administration upon the thymus and bone marrow of the treated mice.
The immunological responsiveness of the host to chemical leukaemogens and
treatment with bone marrow cells might influence the incidence of lymphoma
induction as it was suggested for radiogenic lymphoma (Haran-Ghera and Peled,
1967). The immune reactivity ofthe mice treated with DMBA and marrow cells
was therefore tested by evaluating agglutinating antibodies to Shigella.CHEMICALLY INDUCED LYMPHOMA
MATERIALS AND METHODS
Mice.-Adult C57BL/6 mice ofboth sexes, originally derived from the Jackson
Laboratory, Bar Harbor, Maine, and subsequently maintained in our Animal
Breeding Centre by brother x sister mating, were used for the experiments. The
mice were housed in stainless steel cages and maintained on Purina Laboratory
Chow and water ad libitum.
DMBA treatment.-DMBA was made up as a 1% solution in polyethylene
glycol 400, and administered to the mice by stomach tubes prepared from poly-
ethylene tubing of a pore size of about 1 mm. A dose of 0-1 ml. of the DMBA
solution was given 6 times at 6 day intervals.
X-irracdiation.-The X-irradiation was performed with a General Maximar
250-III machine. The physical factors were: 250 kV, 15 mA, with 1 mm. Al and
0 5 mm. Cu filters: dose rate 61 R/minute for the 200 R and 800 R exposures and
63 R/minute for the 170 R exposure.
Shigella antigen.-The antigen used for the immunological test was Shigella
paradisenteriae and the agglutinin titre measured according to the procedure
described elsewhere (Haran-Ghera and Peled, 1967).
RESULTS
The effect of bone marrow cells on lymphoma induction by DMBA or X-ray
Six week old mice were treated with DMBA intragastrically and divided into
2 groups:
Group 1 received no further treatment.
Group 2 treated similarly was in addition injected with 15 x 106 syngeneic
bone marrow cells (intraveneously) from untreated donors, within an hour
after the 3rd and the 6th DMBA feeding.
Two other groups of mice of the same age were submitted to 4 exposures of
170 R each of total body X-irradiation (totalling 680 R) every 8 days.
Group 3 served as irradiated uninjected controls.
Group 4 received one i.v. injection of syngeneic bone marrow cells suspension
containing 15 x 106 cells within an hour after the last irradiation.
As is shown in Table I, six gastric intubation of DMBA in C57BL/6 mice
yielded a 52 % incidence oflymphoma at a mean age of 26 weeks. A similar rate
of lymphoma-45 %-was observed in mice treated DMBA together with 2
TABLE I.-Incidence ofLymphatic Lymphomas in C57BL/6 Mice given DMBA or
X-ray and Syngeneic Bone Marrow Cells.
Average
No. of latent
No. of mice lymphomas/ Incidence of period
Group Treatment used effective total lymph. (%) (weeks)
1 .DMBA . 50 23/44 . 52 . 26
2 . DMBA+BM (Normal) 33 13/28 . 45 . 24
3 . 170 R x4 . 48 . 37/48 77 . 27
4 . 170 R X4+BM (Normal) . 43 . 12/43 * 28 . 30
5* . 170Rx4+BM (DMBA) . 55 . 18/54 * 33 * 29
* Mice from this group were used for the experiment on the effect ofDMBA on bone marrow cells
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injections of normal bone marrow cells, at a mean age of 24 weeks. In the
irradiated mice injection ofbone marrowcells causedtheincidence oflymphomato
drop from 77 % to 28 % with an average latent period of 27 weeks and 30 weeks
respectively.
The effect ofDMBA on the thymus
Mice of 35 ± 2 days were allocated to 5 groups and given the following treat-
ment:
Group
Group
Group
Group
Group
1: 6 DMBA intubations.
2: 6 DMBA intubations and 2 i.v. injections of marrow cells.
3: 4 irradiations of 170 R.
4: 4 irradiations of 170 R and 1 marrow cells injection.
5: No treatment.
At intervals of5, 10, 15 and 20 days after the last treatment, 10 mice from each
group were killed and thymus weights estimated.
It is evident from the graph in Fig. 1A that the mean thymus weights of mice
fed with DMBA were similar to those of the group which had been treated with
DMBA and marrow cells. A fall in thymus weight occurred during the 10 days
A B
Days
FIG. 1.-Thymus weight following administration of DMBA or X-ray and bone marrow cells.
A. 0 0 DMBA, x- x DMBA + bone marrow, A * untreated.
B. 0 0 X-ray, X x X-ray + bone marrow, A A untreated.
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after treatment followed by a rapid return to normal weight at the 15th day. In
irradiated mice (Fig. iB) the thymus weight fell and stayed constant over the
period ofthe experiment. Injection with bone marrow cells affected the recovery
of the thymus favourably by increasing the thymus weights to 50% above normal
by the 20th day post irradiation.
The effect of DMBA on bone marrow
Bone marrow cells from DMBA treated mice were tested for their effectiveness
in: (a) preventing radiation leukaemogenesis, (b) regenerating the thymus of
sublethally irradiated mice, (c) preventing death of lethally irradiated animals.
Donor mice for marrow cells were treated similarly in all the 3 experiments.
Mice were fed DMBA 6 times at 6 day intervals. One hour after the last DMBA
intubation the marrow from 2 tibiae and 2 femurs was taken into Tyrode's solution.
A suspension containing 15 x 106 bone marrow cells was injected i.v. into irra-
diated mice. Untreated bone marrow injected into irradiated animals or irra-
diated mice alone served as controls.
The number of bone marrow cells found in donors which had been fed with
DMBA was 48 x 106/mouse and in untreated animals 51 x 106/mouse.
Lymphoma prevention was tested in mice irradiated 170 R x 4 and injected
marrow cells from DMBA-treated donors, 1-2 hours after the last irradiation.
Since the experiment was performed in parallel with that described in Table I, the
control groups served for both experiments. It was found that the same degree
of lymphoma prevention was achieved by marrow cells from DMBA-treated
mice-33 %, as by marrow cells from untreated donors-28 %.
Thymus regeneration of mice exposed to 2 irradiation of 200 R at 7 day
intervals was tested by injecting-1-2 hours after the last irradiation-bone
marrow cells, either from DMBA-treated mice or from untreated donors. Experi-
mental data indicated (Table II) that the thymus recovers equally whether by
treated or untreated bone marrow cells, as is shown by the thymus weights, 21
days after treatment.
TALBE II.-Effect ofBone Marrow Pretreated with DMBA on Thymic
Recovery in Sublethally Irradiated Mice
Mean thymic weight
± standard deviation
Group Treatment No. of mice (mg.)
1 200 R x 2 followed by bone marrow
from DMBA pretreated mice . 10 . 41.4±7.1
2 200 R x 2 followed by normal bone
marrow . 10 . 56.4±7.6
3 . 200 R x2 . 10 . 19.0±2.9
4 . None . 10 . 47.3±3.6
The effectiveness of DMBA pretreated bone marrow to prevent death of
lethally irradiated mice was tested in 3 month old mice exposed to 800 R. As
shown in Table III, 6 months following irradiation, 100 % of the mice survived if
they were injected with bone marrow from DMBA-treated mice or normal animals.
All the irradiated control mice died at day 13.
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TABLE III.-Effect ofBone Marrow Pretreated with DMBA on the Survival
ofLethally Irradiated Mice
Treatment 6-month survival rate Per cent survival
800 R followed by bone marrow from DMBA
pretreated mice 14/14 . 100
800 R followed by normal bone marrow . 14/14 . 100
800 R 0114 . 0
The immune reactivity of mice treated DMBA and bone marrow cells
Production of circulating antibodies to Shigella antigen was tested after the
following treatments:
Group 1: DMBA.
Group 2: DMBA together with bone marrow cells.
Group 3: Irradiation 170 R x 4.
Group 4: Irradiation 170 R X 4 followed by 1 injection of bone marrow cells.
Group 5: Untreated.
These groups of mice were injected i.p with Shigella 24 hours after completion
of the treatment. The sera were collected 8 days after Shigella inoculation and
tested for agglutinating antibodies. The antibody response expressed in the mean
log2 titre is summarized in Table IV. DMBA intubation administered either
alone or together with bone marrow cells causes a reduction in the production of
antibodies from the normal level of 8-4 to 4-0 and 4-3 respectively.
TABLE IV.-Antibody Titres in Mice Treated with DMBA or X-rays and
Bone Marrow Cells
Group Treatment No. of mice tested Log2 of titre (mean)
1 . DMBA . 11 . 4-0
2 . DMBA+bone marrow 9 . 4-3
3 . 170Rx4 . 10 . 4-0
4 170 R x4+bone marrow . 5 . 6-0
5 . Untreated . 9 . 8-4
Antibody production in mice receiving whole-body irradiation was reduced
to 4-0, but augmented by bone marrow injection to a mean log2 titre of 6-0.
DISCUSSION
In the present experiment injection of syngeneic bone marrow cells into
C57BL/6 mice which had been pretreated with DMBA did not exert protection
against lymphoma as had been observed in irradiated mice of the same strain and
age. The results-tend to confirm our previous observations (Berenblum et al.,
1966; Chen and Berenblum, 1968) on the inability ofbone marrow cells to inhibit
chemical leukaemogenesis.
In a previous radiobiological investigation undertaken by Kaplan et al. (1953)
it was shown that radiation produces injury to the thymus and bone marrow cells.
Arapidrestoration ofthe damaged thymus became evident only inirradiated hosts
supplied with bone marrow cells from an untreated syngeneic host. It was
proposed that the effect of the marrow cells on promoting thymus regeneration
after irradiation is causally linked to its protective effect against lymphoma
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development. The present findings furnished evidence of a different action ofthe
chemical leukaemogen upon the thymus and bone marrow cells. Thymuses of
mice treated with DMBA revealed a temporary damage (as is reflected in their
weights) for about 10 days after the chemical intubation, followed by a rapid
recovery on day 15. In the mice injected with bone marrow in addition to
DMBA, the thymuses showed a similar pattern of regeneration as in uninjected
animals-suggesting that the recovery from the thymus injury sustained by the
chemical is not affected by the marrow cells. In marked contrast to the effect of
the DMBA treatment, irradiation produces prolonged damage to the thymus.
The repair is arrested for at least 3 weeks and full recovery (Cividalli and Knys-
zynski, 1967) is achieved only a month after irradiation. A strikingly rapid
regeneration during the second week is observed in mice injected bone marrow
cells soon after the last irradiation.
Another effect of the X-radiation is the damage to the exposed marrow, ex-
pressed as a loss of its capacity to promote thymic regeneration and therefore to
prevent lymohoma development (Kaplan, 1964). In contrast to the radiation
effect upon the bone marrow it appears from the results reported here that
chemically induced lymphoma in adult mice is not linked to inactivation of bone
marrow cells since injection of untreated marrow cells does not reverse the course
ofleukaemogenesis. A destructive effect ofDMBA on the protective factor of the
injected marrow cells appears unlikely since marrow cells from mice pretreated
DMBA are effective in preventing lymphoma induction by X-ray as marrow cells
from untreated donors. Thymus regeneration of sublethally irradiated mice or
death prevention of lethally irradiated animals were also equally affected either
by normal or by DMBA-treated marrow cells.
The present findings provide further support for the view that bone marrow
cells inhibit a specific stage in radiation leukaemogenesis and are not concerned
with the leukaemia process as such, irrespective ofthe nature ofthe leukaemogenic
agent. Other forms ofleukaemia, spontaneous (Miller, 1960) or oestrogen induced
(Toch et al., 1956) are not inhibited by bone marrow either. Also suggestive are
the findings of Congdon et al. (1964) on the inability of transplanted bone marrow
cells to cause recovery from the acute chemical toxicity of DMBA.
There is evidence (Prehn and Main, 1957) that an interference by the carcinogen
with the host's normal immune defence may promote tumour induction. Chemical
carcinogens were shown to depress the immunologic response of mice to sheep
erythrocytes (Malmgren etat., 1952) and to interfere with some homograft reactions
(Rubin, 1960). In view of the possibility that radiogenic and chemical induced
lymphomas are viral in origin, it was suggested (Haran-Ghera and Peled, 1967)
that radiation, by weakening the immune defence of the host, facilitates the
activation of the virus, whereas marrow cells, by restoring the immune response,
might prevent its activity. Under the appropriate conditions, however, it appears
that bone marrow cells do not restore the immune response of the host, depressed
by the leukaemogenic dose of DMBA. It seems that the immune restoration
factor in the bone marrow ofDMBA treated mice was not impaired by the chemical
since marrow cells from such mice were shown to prevent radiogenic lymphoma.
It was demonstrated histologically by McEndy et al. (1942) that, following treat-
ment with MC, changes occur in the lymph nodes and spleen but not in bone
marrow. Ifwe assume that antibody formation is a chain ofevents, then different
carcinogens, chemical or physical, might effect alterations on different links and
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depression of the immune reaction may not necessarily be related to the bone
marrow damage.
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